Veru Inc Sustainability Reports
Veru Inc. is a late clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic and inflammatory diseases, with programs including enobosarm and sabizabulin.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900ER63TFLEIJV631
5 reports from 2017 to 2023